Home/Filings/4/0001144204-17-021133
4//SEC Filing

Dipexium Pharmaceuticals, Inc. 4

Accession 0001144204-17-021133

CIK 0001497504operating

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 6:31 AM ET

Size

6.0 KB

Accession

0001144204-17-021133

Insider Transaction Report

Form 4
Period: 2017-01-17
Shawah Robert G.
Chief Accounting Officer
Transactions
  • Award

    Options

    2017-01-17+130,000130,000 total
    Exercise: $1.80Exp: 2027-01-17Common Stock (130,000 underlying)
Footnotes (1)
  • [F1]Options to purchase shares of common stock vest as follows: options to purchase 65,000 shares of common stock vested on January 17, 2017; options to purchase 2,708 shares of common stock vest monthly in each of the 23 months after the date of grant and options to purchase 2,716 shares of common stock will vest on the 24th month anniversary of the date of grant.

Issuer

Dipexium Pharmaceuticals, Inc.

CIK 0001497504

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001497504

Filing Metadata

Form type
4
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 6:31 AM ET
Size
6.0 KB